These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 31963435)

  • 21. Genetics of Parkinson disease.
    Domingo A; Klein C
    Handb Clin Neurol; 2018; 147():211-227. PubMed ID: 29325612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of recent genetic findings in Parkinson's disease.
    Klein C; Lohmann-Hedrich K
    Curr Opin Neurol; 2007 Aug; 20(4):453-64. PubMed ID: 17620882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly-ADP-ribose assisted protein localization resolves that DJ-1, but not LRRK2 or α-synuclein, is localized to the mitochondrial matrix.
    Osuagwu N; Dölle C; Tzoulis C
    PLoS One; 2019; 14(7):e0219909. PubMed ID: 31323073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1.
    Kamp F; Exner N; Lutz AK; Wender N; Hegermann J; Brunner B; Nuscher B; Bartels T; Giese A; Beyer K; Eimer S; Winklhofer KF; Haass C
    EMBO J; 2010 Oct; 29(20):3571-89. PubMed ID: 20842103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.
    Cook L; Verbrugge J; Schwantes-An TH; Schulze J; Foroud T; Hall A; Marder KS; Mata IF; Mencacci NE; Nance MA; Schwarzschild MA; Simuni T; Bressman S; Wills AM; Fernandez HH; Litvan I; Lyons KE; Shill HA; Singer C; Tropea TF; Vanegas Arroyave N; Carbonell J; Cruz Vicioso R; Katus L; Quinn JF; Hodges PD; Meng Y; Strom SP; Blauwendraat C; Lohmann K; Casaceli C; Rao SC; Ghosh Galvelis K; Naito A; Beck JC; Alcalay RN
    Brain; 2024 Aug; 147(8):2668-2679. PubMed ID: 39074992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of oxidative stress in Parkinson's disease.
    Dias V; Junn E; Mouradian MM
    J Parkinsons Dis; 2013; 3(4):461-91. PubMed ID: 24252804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The LRRK2-macroautophagy axis and its relevance to Parkinson's disease.
    Manzoni C
    Biochem Soc Trans; 2017 Feb; 45(1):155-162. PubMed ID: 28202669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular pathogenesis of Parkinson's disease: update.
    Saiki S; Sato S; Hattori N
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):430-6. PubMed ID: 22138181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding insights of mitochondrial dysfunction in Parkinson's disease.
    Abou-Sleiman PM; Muqit MM; Wood NW
    Nat Rev Neurosci; 2006 Mar; 7(3):207-19. PubMed ID: 16495942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of autophagy in Parkinson's disease.
    Lynch-Day MA; Mao K; Wang K; Zhao M; Klionsky DJ
    Cold Spring Harb Perspect Med; 2012 Apr; 2(4):a009357. PubMed ID: 22474616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging pathways in genetic Parkinson's disease.
    Lewis PA
    FEBS J; 2008 Dec; 275(23):5747. PubMed ID: 19021751
    [No Abstract]   [Full Text] [Related]  

  • 33. PGC-1s in the Spotlight with Parkinson's Disease.
    Piccinin E; Sardanelli AM; Seibel P; Moschetta A; Cocco T; Villani G
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33800548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mitochondrial dysfunction and oxidative damages in the molecular pathology of Parkinson's disease].
    Shadrina MI; Slominskiĭ PA
    Mol Biol (Mosk); 2008; 42(5):809-19. PubMed ID: 18988530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular insights into Parkinson's disease.
    Rochet JC; Hay BA; Guo M
    Prog Mol Biol Transl Sci; 2012; 107():125-88. PubMed ID: 22482450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics and epigenetics of Parkinson's disease.
    Coppedè F
    ScientificWorldJournal; 2012; 2012():489830. PubMed ID: 22623900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia.
    Kim T; Vemuganti R
    J Cereb Blood Flow Metab; 2017 Jun; 37(6):1910-1926. PubMed ID: 28273718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum.
    Melo TQ; Copray SJCVM; Ferrari MFR
    Neurochem Res; 2018 Dec; 43(12):2212-2223. PubMed ID: 30370500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodegeneration: Impact of S-nitrosylated Parkin, DJ-1 and PINK1 on the pathogenesis of Parkinson's disease.
    Sircar E; Rai SR; Wilson MA; Schlossmacher MG; Sengupta R
    Arch Biochem Biophys; 2021 Jun; 704():108869. PubMed ID: 33819447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the molecular causes of Parkinson's disease.
    Wood-Kaczmar A; Gandhi S; Wood NW
    Trends Mol Med; 2006 Nov; 12(11):521-8. PubMed ID: 17027339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.